Alnylam Pharmaceuticals, Inc. financial data

Symbol
ALNY on Nasdaq
Location
675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 277 % -7.36%
Quick Ratio 5.69 % -30.6%
Debt-to-equity 2.58K %
Return On Equity 26.1 % -91.9%
Return On Assets 0.98 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 132M shares +2.43%
Common Stock, Shares, Outstanding 132M shares +2.29%
Entity Public Float 31B USD +31%
Common Stock, Value, Issued 1.32M USD +2.25%
Weighted Average Number of Shares Outstanding, Basic 131M shares +2.22%
Weighted Average Number of Shares Outstanding, Diluted 137M shares +6.81%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.21B USD +53.2%
Research and Development Expense 1.25B USD +13.6%
Costs and Expenses 2.95B USD +29%
Operating Income (Loss) 265M USD
Nonoperating Income (Expense) -297M USD -123%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -31.9M USD +90.1%
Income Tax Expense (Benefit) -75.5M USD -777%
Net Income (Loss) Attributable to Parent 43.6M USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.49B USD +35.5%
Accounts Receivable, after Allowance for Credit Loss, Current 965M USD +173%
Inventory, Net 75.4M USD -0.8%
Assets, Current 3.95B USD +17.8%
Deferred Income Tax Assets, Net 98.6M USD
Property, Plant and Equipment, Net 502M USD -1.03%
Operating Lease, Right-of-Use Asset 191M USD -2.56%
Other Assets, Noncurrent 55.8M USD -28.1%
Assets 4.85B USD +15.4%
Accounts Payable, Current 118M USD +66.1%
Employee-related Liabilities, Current 214M USD +75.5%
Accrued Liabilities, Current 1.15B USD +21.9%
Contract with Customer, Liability, Current 2.54M USD -96.4%
Liabilities, Current 1.56B USD +27.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 223M USD -5.34%
Other Liabilities, Noncurrent 9.77M USD -97.3%
Liabilities 4.62B USD +10.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -21.8M USD +12.3%
Retained Earnings (Accumulated Deficit) -7.16B USD +0.61%
Stockholders' Equity Attributable to Parent 234M USD +623%
Liabilities and Equity 4.85B USD +15.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -118M USD -45.1%
Net Cash Provided by (Used in) Financing Activities 44.1M USD +52.5%
Net Cash Provided by (Used in) Investing Activities 114M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 132M shares +2.29%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 53.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.49B USD +35.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 66.9M USD +116%
Deferred Tax Assets, Valuation Allowance 2.79B USD -1.01%
Deferred Tax Assets, Gross 2.97B USD +2.43%
Operating Lease, Liability 271M USD -4.63%
Payments to Acquire Property, Plant, and Equipment 8.97M USD -30.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 46.6M USD
Lessee, Operating Lease, Liability, to be Paid 384M USD -8.03%
Property, Plant and Equipment, Gross 773M USD +3.21%
Operating Lease, Liability, Current 44.8M USD +6.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.2M USD -0.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 43.4M USD -0.47%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 9.64M USD +2023%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 113M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 41.6M USD +2.32%
Deferred Tax Assets, Operating Loss Carryforwards 883M USD +9.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 53.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 40.5M USD +3.89%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 368M USD +65.6%
Interest Expense 128M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%